Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
China Journal of Traditional Chinese Medicine and Pharmacy ; (12)2005.
Artigo em Chinês | WPRIM | ID: wpr-564829

RESUMO

Through researching YE Tian-shi’s theory source,the point of therapeutic methods of Qi collateral asthenia syndrome and collaterals diseases,attaching importance to physique factor and treating in accordance with seasonal conditional,this thesis expatiated intensively YE Tian-shi’s theory of therapeutical principle and medication trait for Qi collateral diseases.Then enumerated the prescriptions in common usage for Qi collateral diseases which were well-chosen from YE Tian-shi’s medical record.In a way,this thesis embodied the academic thought of paying particular attention to Qi collateral therapeutic methods in YE Tianshi’s theory very well.

2.
China Journal of Traditional Chinese Medicine and Pharmacy ; (12)2005.
Artigo em Chinês | WPRIM | ID: wpr-679841

RESUMO

Hepatolenticular degeneration,namely Wilson's disease,an autosomal recessive disorder of copper metabolism.The author of this article gave a definition to toxin-pathogen,discussed the basic concept of collaterals disease briefly.And pointed out that hepatolenticular degeneration is a disease due to toxin-pathogen invading collaterals,which was caused by disorder of copper metabolism.This can result in toxin stagnating in collaterals and stagnation of blood stasis in collaterals in the initial stage,and collaterals injured at last.To improve QI-blood circulation and regulate the function of zang fu is important in order to accelerate elimination of toxin and prevent copper from stagnating. Specific therapy vary according to different clinical symptoms,such as promoting blood circulation for removing obstruction in collaterals and clearing toxin, clearing heat-fire and clearing toxin and dispersing stagnated liver-qi for promoting bile flow et al.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA